EY launches smart reviewer
Ernst & Young (EY) is launching the EY Smart Reviewer, software that utilizes artificial intelligence and natural language processing to help companies review materials used to market pharmaceutical and medical device products. Read More
Salmonella shows promise as cancer therapy
Salmonella may be useful as a bacterial delivery vector for cancer therapy, according to research published October 21 in Nature Communications. Read More
FDA authorizes COVID-19 vaccine booster shots
Johnson & Johnson and Moderna have received emergency use authorization from the U.S. Food and Drug Administration (FDA) for booster shots of their COVID-19 vaccines. Read More
FDA grants orphan drug designation to Intellia's NTLA-2001
The U.S. Food and Drug Administration has granted an orphan drug designation to Intellia Therapeutics' NTLA-2001 therapy for the treatment of transthyretin amyloidosis. Read More
Waters, U. of Delaware to collaborate on biopharma processing
Waters and the University of Delaware have initiated a five-year collaboration focused on improving quality, yields, and efficiency in the manufacturing processes for biologics and new modalities. Read More
Selecta and Genovis enter exclusive license agreement
Selecta Biosciences and Genovis have inked a strategic licensing agreement to advance a next-generation immunoglobulin G protease for use in gene therapy and certain autoimmune diseases. Read More
Twist launches exome panel for genomics research
Twist Bioscience has launched Exome 2.0, an exome panel for genomics research. Read More
Viome, GSK to develop cancer, autoimmune disease therapies
Viome Life Sciences has expanded its partnership with GlaxoSmithKline (GSK) to develop potential therapies for cancer and autoimmune diseases. Read More
Biotage acquires ATDBio for $62M
Biotage acquired the U.K.-based privately held company ATDBio for $62 million (45 million pounds). Read More
Unchained Labs launches new automation software
Unchained Labs has released its LEA 10 automation software, which aims to enable researchers to navigate workflow bottlenecks and scientific challenges. Read More
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter